iHeart Japan Corporation
PrivateLast Round
Series D
Sep 1, 2023
Total Funding Raised
$29.72M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
iHeart Japan Corporation operates in Healthcare & Life Sciences and is based in Kyoto. Its latest recorded funding round was a Series D round in September 2023.
iHeart Japan Corporation is a biotechnology company that develops allogeneic regenerative medical products derived from iPS cells for the treatment of heart failure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iHeart Japan Corporation Comparables
Compare iHeart Japan Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Metcela Inc. | 88% | |
| Heartseed | 85% | |
| Cuorips Inc. | 84% |
For institutional investors. Book with your work email.
iHeart Japan Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 1, 2023 | ||||
| Series C | Jul 6, 2021 | ||||
| Series A | Nov 30, 2017 | ||||
| Series B | May 16, 2016 |
For institutional investors. Book with your work email.
iHeart Japan Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SMBC Nikko Securities | Series D |
| Mizuho Capital | Series C |
| UTEC (The University of Tokyo Edge Capital Partners) | Series D |
| Joyo Capital Partners | Series D |
| Resona Capital | Series C |
| Mitsui Sumitomo Insurance | Series D |
| 株式会社ヘルスケア・イノベーション | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 34% MoM, reaching 1.9K.
- Sep 1, 2025
$6M round led by MS&AD Ventures and Mitsui Sumitomo Insurance
For institutional investors. Book with your work email.
iHeart Japan Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about iHeart Japan Corporation's valuation, stock price, and market status.
Is iHeart Japan Corporation a public or private company?
iHeart Japan Corporation is a private company.
What is the current stock price of iHeart Japan Corporation?
iHeart Japan Corporation is a private company, so its shares have no public market price. Caplight tracks iHeart Japan Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iHeart Japan Corporation worth (valuation)?
Valuation information for iHeart Japan Corporation is not publicly available.
Can I buy iHeart Japan Corporation stock?
iHeart Japan Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iHeart Japan Corporation's last funding round?
iHeart Japan Corporation's most recent funding round was Series D on September 1, 2023.
Who are the main investors in iHeart Japan Corporation?
Key investors in iHeart Japan Corporation include Mitsui Sumitomo Insurance, MS&AD Ventures, Mitsui Sumitomo Insurance Capital Co., Ltd., SPARX Group.
Will iHeart Japan Corporation IPO soon?
No public IPO plans have been announced for iHeart Japan Corporation.
How can I track iHeart Japan Corporation secondary market activity?
Caplight tracks bids, offers, and trades in iHeart Japan Corporation's shares on secondary markets.